Daniel J. Brennan

2018

In 2018, Daniel J. Brennan earned a total compensation of $3.7M as Executive Vice President and Chief Financial Officer at Boston Scientific, a 1% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$102,017
Non-Equity Incentive Plan$626,736
Option Awards$562,495
Salary$621,637
Stock Awards$1,719,882
Other$33,058
Total$3,665,825

Brennan received $1.7M in stock awards, accounting for 47% of the total pay in 2018.

Brennan also received $102K of change in pension value and nonqualified deferred compensation earnings, $626.7K in non-equity incentive plan, $562.5K in option awards, $621.6K in salary and $33.1K in other compensation.

Rankings

In 2018, Daniel J. Brennan's compensation ranked 3,080th out of 14,244 executives tracked by ExecPay. In other words, Brennan earned more than 78.4% of executives.

ClassificationRankingPercentile
All
3,080
out of 14,244
78th
Division
Manufacturing
1,142
out of 5,759
80th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
134
out of 849
84th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
68
out of 547
88th
Industry
Surgical and Medical Instruments and Apparatus
41
out of 348
88th

Pay ratio

Daniel J. Brennan's Pay$3,665,825
Median Employee's Pay$62,447
Pay Ratio

59

to 1

In 2018, the annual total compensation of Daniel J. Brennan was $3,665,825.

The annual total compensation of the median employee at Boston Scientific was $62,447.

The ratio of Daniel J. Brennan's pay to the pay of median employee was therefore 59 to one.

Source: SEC filing on March 27, 2019.

Brennan's colleagues

We found four more compensation records of executives who worked with Daniel J. Brennan at Boston Scientific in 2018.

2018

Michael Mahoney

Boston Scientific

Chief Executive Officer

2018

Joseph Fitzgerald

Boston Scientific

Executive Vice President and President, Rhythm Management

2018

Kevin Ballinger

Boston Scientific

Executive Vice President and President, Interventional Cardiology

2018

David Pierce

Boston Scientific

Executive Vice President and President, MedSurg

News

You may also like